Mitchell Sabloff profile picture

Contact Information

Mitchell Sabloff, MSc, MDCM, FRCPC
613-737-8899 x79670
Msabloff@toh.on.ca

ORCID logo https://orcid.org/0000-0002-0122-6138

News

Precision medicine approach for leukemia awarded $1.5M
May 1, 2019 - Acute myeloid leukemia (AML) is one of the deadliest forms of cancer. A team of researchers from The Ottawa Hospital and uOttawa is hoping to revolutionize treatment for AML by developing a “precision medicine” approach.
New drug combination destroys chemo-resistant blood cancer
October 22, 2018 - Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely ...
Bolstering fat cells offers new hope for treating blood cancer
November 6, 2017 - Drs. Mitchell Sabloff and David Allan contributed to a new study led out of McMaster University that is providing hope for people with acute myeloid leukemia (AML). This kind of cancer grows in the bone marrow and inhibits the production of normal bl